EVALUATE THE MORPHOLOGICAL CHANGES AND HEART FUNCTION IN PATIENTS WITH THALASSEMIA AT THE CENTER OF PEDIATRIC THAI NGUYEN NATIONAL HOSPITAL
Main Article Content
Abstract
Objectives: Evaluate the morphological changes and heart function, and describes some of the factors related to the changing morphology and cardiac function in patients Thalassemia. Methods: Describe case series study. Subjects: 26 patients Thalassemia were treated at the center for Pediatric medicine - Thai Nguyen National Hospital from 2/2020 to 2/2021. Results: Radiograph, 57.7% had enlarged heart shadow; Electrocardiogram, 84.6% had tachycardia; cardiac ultrasound, 53.8% of children had mitral valve regurgitation, 30.8% had heart failure, 26,9% had decreased myocardial contractility and 19.2% had left ventricular dilatation. Elevated serum ferritin concentrations ≥ 2000ng/ml and morbidity over 5 years are risk factors for cardiac complications in patients with Thalassemia. Conclusion: Cardiovascular morphology and heart function changes in patients with Thalassemia are mainly enlarged heart, tachycardia, mitral valve regurgitation, and heart failure, decreased myocardial contractility, and left ventricular dilation. There is a relationship between serum ferritin concentration and duration of disease and cardiac complications in patients with Thalassemia.
Article Details
Keywords
Thalassemia, changes in heart morphology and function
References
2. Nguyễn Việt Hà, Nguyễn Ngọc Sáng, Vũ Văn Quang (2018), “Biến đổi tim mạch ở bệnh nhân Betha Thalassemia tại bệnh viện trẻ em Hải Phòng”, Tạp chí Y học Việt Nam, tập 466, tháng 5 số đặc biệt, tr 481-485.
3. Mã Phương Hạnh (2009), “ Đặc điểm bệnh nhân Thalassemia thể nặng có ứ sắt tại bệnh viện Nhi đồng I”, Tap chí Y học thành phố Hồ Chí Minh, phụ bản tập 13 số 1, chuyên đề Nhi khoa, tr 167-173.
4. Borgana-Pignatti C, Rugoloto S, De Stefano P, et al (2004), “Survival and complications in patients with thalassemia major treated with transfusion and defeoxamine”, Haematologica, Page 1187-1193.
5. Cappellini MD., Cohen A., Androulala E. et al (2008). Guidelines for the clinical management of thalassemia. Thalassaemia International Federation, 2nd edition.
6.Nouri N, Naderi M, Rajaie S et al (2013). “Evaluation of cardiac function in patients with thalassemia intermedia. Iran J Ped Hematol Oncol”. 3(1): Page 193-199.
7. Sultan Aydın Köker, Gönül Oktay, Derya Duman et al (2019). “Assessment of cardiac functions in thalassemia patients with m-mode echocardiography ”. Cumhuriyet Medical Journal, Volume: 41, Number: 4, Page 739-742
8. Thalassemia Internation Federation annual report 2013.